Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lucas, Jacquin"'
Autor:
Guillaume Becker, Tania Deprez, Mohamed Ali Bahri, Alain Plenevaux, Fabian Hustadt, Christian Lemaire, Georges Mairet-Coello, Anne Michel, Catherine De Wolf, Lucas Jacquin, Eric Gillent, Aline Freyssin, Martin Citron, Erwan Bezard, Mélina Caruso, Jean-Marie Frequin, André Luxen, Gaëtan Garraux, Patrick Downey
Publikováno v:
Neurobiology of Aging. 107:142-152
With the emergence of disease-modifying therapies for Parkinson's disease, reliable longitudinal markers are needed to quantify pathology and demonstrate disease progression. We developed the A53T-AAV rat model of synucleinopathy by combining longitu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2d97855b19689590e7d238ba49b7a74
https://doi.org/10.1016/j.neurobiolaging.2021.07.012
https://doi.org/10.1016/j.neurobiolaging.2021.07.012
Autor:
Jeroen Verhoeven, Caroline Van den Broecke, Seon-Ah Chong, Karine Leclercq, Christian Vanhove, Charlotte Germonpré, Lucas Jacquin, Ingeborg Goethals, Wytse Wadman, Kristl Vonck, Véronique M. André, Charlotte Bouckaert, Paul Boon, Benedicte Descamps, Robrecht Raedt, Evelien Carrette, Sam Donche, Filip De Vos, Georges Mairet-Coello
Publikováno v:
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
International Journal of Molecular Sciences
Volume 21
Issue 19
International Journal of Molecular Sciences, Vol 21, Iss 6999, p 6999 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 19
International Journal of Molecular Sciences, Vol 21, Iss 6999, p 6999 (2020)
Seizures are common in patients with high-grade gliomas (30&ndash
60%) and approximately 15&ndash
30% of glioblastoma (GB) patients develop drug-resistant epilepsy. Reliable animal models are needed to develop adequate treatments for glioma
60%) and approximately 15&ndash
30% of glioblastoma (GB) patients develop drug-resistant epilepsy. Reliable animal models are needed to develop adequate treatments for glioma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd595d7d20820a53738017bdec2764d7
https://biblio.ugent.be/publication/8675526
https://biblio.ugent.be/publication/8675526
Autor:
Guillaume, Becker, Anne, Michel, Mohamed Ali, Bahri, Georges, Mairet-Coello, Christian, Lemaire, Tania, Deprez, Aline, Freyssin, Lucas, Jacquin, Fabian, Hustadt, Catherine, De Wolf, Mélina, Caruso, Jean-Marie, Frequin, Eric, Gillent, Erwan, Bezard, Gaetan, Garraux, André, Luxen, Martin, Citron, Patrick, Downey, Alain, Plenevaux
Publikováno v:
Neurobiology of aging. 107
With the emergence of disease-modifying therapies for Parkinson's disease, reliable longitudinal markers are needed to quantify pathology and demonstrate disease progression. We developed the A53T-AAV rat model of synucleinopathy by combining longitu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f2d539ce35f368964fbe54ffe50ea980
https://pubmed.ncbi.nlm.nih.gov/34433125
https://pubmed.ncbi.nlm.nih.gov/34433125